HIGHLIGHTS
- who: Zoufang Huang from the Department of Hematology, Ganzhou Key Laboratory of Hematology, The First Affiliated Hospital of Gannan Medical University, Ganzhou, China have published the paper: CAR T cells: engineering immune cells to treat brain cancers and beyond, in the Journal: (JOURNAL)
- future: An enhanced focus on the identification of ideal target antigens is an important area of future research that is required to achieve the potential of CAR T_cell therapy for any form of solid tumors. Clinical trials using CAR T therapy have demonstrated progressionfree survival for over a year however additional research . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.